Taking Ozempic? A routine eye exam could help you understand your risk for vision loss.

OpenBook market desk: Some research suggests that GLP-1 drugs may raise the risk of a rare eye disease that causes full or partial vision loss.

Why this matters for multi-asset traders

The headline theme is "Taking Ozempic? A routine eye exam could help you understand your risk for vision loss.". We reframe the story for readers tracking equities, FX majors and crypto liquidity - without copying the original wording.

Watch related price action on OpenBook movers and treat this note as information, not investment advice.

Based on reporting from MarketWatch. Read the original.